Cargando…

Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery

Primary liver cancer was the seventh most diagnosed cancer and the second leading cause of cancer death with about 906,000 cases and 830,000 deaths, respectively, in 2020. Conventional treatment for liver cancer, such as transarterial chemoembolization (TACE) or sorafenib, has limitations in that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Da Bin, Lee, Do Kyeong, Cheon, Chunhoo, Ribeiro, Rosy Iara Maciel A., Kim, Bonglee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610711/
https://www.ncbi.nlm.nih.gov/pubmed/36296934
http://dx.doi.org/10.3390/nu14204252
_version_ 1784819344334651392
author Kim, Da Bin
Lee, Do Kyeong
Cheon, Chunhoo
Ribeiro, Rosy Iara Maciel A.
Kim, Bonglee
author_facet Kim, Da Bin
Lee, Do Kyeong
Cheon, Chunhoo
Ribeiro, Rosy Iara Maciel A.
Kim, Bonglee
author_sort Kim, Da Bin
collection PubMed
description Primary liver cancer was the seventh most diagnosed cancer and the second leading cause of cancer death with about 906,000 cases and 830,000 deaths, respectively, in 2020. Conventional treatment for liver cancer, such as transarterial chemoembolization (TACE) or sorafenib, has limitations in that there is the recurrence of cancer, drug inefficacy, and adverse effects. Traditional medicine and natural products of several regions including Korea, China, Europe, North America, India, and the Middle East have attracted a lot of attention since they have been reported to have anticancer effects with low adverse effects. In this review, several in vivo studies on the effects of natural compounds on liver cancer and clinical trials approving their therapeutic benefits were selected and discussed. As a result of the analysis of these studies, the effects of natural compounds were classified into a few mechanisms: apoptosis, anti-metastasis, and antiangiogenesis. In addition, medications including natural products in clinical trials were observed to exhibit improvements in various liver cancer symptoms and patients’ survival rates. This study presents findings suggestive of the anticancer potential of natural products and their properties in relieving related symptoms.
format Online
Article
Text
id pubmed-9610711
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96107112022-10-28 Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery Kim, Da Bin Lee, Do Kyeong Cheon, Chunhoo Ribeiro, Rosy Iara Maciel A. Kim, Bonglee Nutrients Review Primary liver cancer was the seventh most diagnosed cancer and the second leading cause of cancer death with about 906,000 cases and 830,000 deaths, respectively, in 2020. Conventional treatment for liver cancer, such as transarterial chemoembolization (TACE) or sorafenib, has limitations in that there is the recurrence of cancer, drug inefficacy, and adverse effects. Traditional medicine and natural products of several regions including Korea, China, Europe, North America, India, and the Middle East have attracted a lot of attention since they have been reported to have anticancer effects with low adverse effects. In this review, several in vivo studies on the effects of natural compounds on liver cancer and clinical trials approving their therapeutic benefits were selected and discussed. As a result of the analysis of these studies, the effects of natural compounds were classified into a few mechanisms: apoptosis, anti-metastasis, and antiangiogenesis. In addition, medications including natural products in clinical trials were observed to exhibit improvements in various liver cancer symptoms and patients’ survival rates. This study presents findings suggestive of the anticancer potential of natural products and their properties in relieving related symptoms. MDPI 2022-10-12 /pmc/articles/PMC9610711/ /pubmed/36296934 http://dx.doi.org/10.3390/nu14204252 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Da Bin
Lee, Do Kyeong
Cheon, Chunhoo
Ribeiro, Rosy Iara Maciel A.
Kim, Bonglee
Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title_full Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title_fullStr Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title_full_unstemmed Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title_short Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
title_sort natural products for liver cancer treatment: from traditional medicine to modern drug discovery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610711/
https://www.ncbi.nlm.nih.gov/pubmed/36296934
http://dx.doi.org/10.3390/nu14204252
work_keys_str_mv AT kimdabin naturalproductsforlivercancertreatmentfromtraditionalmedicinetomoderndrugdiscovery
AT leedokyeong naturalproductsforlivercancertreatmentfromtraditionalmedicinetomoderndrugdiscovery
AT cheonchunhoo naturalproductsforlivercancertreatmentfromtraditionalmedicinetomoderndrugdiscovery
AT ribeirorosyiaramaciela naturalproductsforlivercancertreatmentfromtraditionalmedicinetomoderndrugdiscovery
AT kimbonglee naturalproductsforlivercancertreatmentfromtraditionalmedicinetomoderndrugdiscovery